{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:21:42Z","timestamp":1788142902077,"version":"build-2803163510"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.crohns.2010.08.007","type":"journal-article","created":{"date-parts":[[2010,10,19]],"date-time":"2010-10-19T09:54:44Z","timestamp":1287482084000},"page":"48-53","source":"Crossref","is-referenced-by-count":28,"title":["Assessment of non-cirrhotic portal hypertension associated with thiopurine therapy in inflammatory bowel disease"],"prefix":"10.1093","volume":"5","author":[{"given":"Emma","family":"Calabrese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Hanauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1016\/j.crohns.2010.08.007_bb0005","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0140-6736(96)90402-X","article-title":"Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine","volume":"347","author":"Bouhnik","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.crohns.2010.08.007_bb0010","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/gut.39.3.401","article-title":"6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity","volume":"39","author":"Cuffari","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2010.08.007_bb0015","first-page":"1198","article-title":"Long-term experience with 6-mercaptopurine in the treatment of Crohn's disease","volume":"88","author":"Korelitz","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2010.08.007_bb0020","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/BF01318372","article-title":"Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease","volume":"30","author":"Korelitz","year":"1985","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.crohns.2010.08.007_bb0025","first-page":"CD000545","article-title":"Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease","author":"Prefontaine","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.crohns.2010.08.007_bb0030","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM198005013021801","article-title":"Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study","volume":"302","author":"Present","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crohns.2010.08.007_bb0035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1053\/bega.2002.0346","article-title":"Optimizing treatment with thioguanine derivatives in inflammatory bowel disease","volume":"17","author":"Louis","year":"2003","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"9","key":"10.1016\/j.crohns.2010.08.007_bb0040","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/ibd.21221","article-title":"Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8-year intercept cohorts","volume":"16","author":"Jharap","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2010.08.007_bb0045","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/003655298750027290","article-title":"Azathioprine: state of the art in inflammatory bowel disease","volume":"225","author":"Sandborn","year":"1998","journal-title":"Scand J Gastroenterol Suppl"},{"key":"10.1016\/j.crohns.2010.08.007_bb0050","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00228-008-0478-6","article-title":"Clinical pharmacology and pharmacogenetics of thiopurines","volume":"64","author":"Sahasranaman","year":"2008","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.crohns.2010.08.007_bb0055","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1053\/gast.2002.32420","article-title":"6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease","volume":"122","author":"Dubinsky","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2010.08.007_bb0060","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","article-title":"Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease","volume":"118","author":"Dubinsky","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2010.08.007_bb0065","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1572-0241.2003.07413.x","article-title":"Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine","volume":"98","author":"Dubinsky","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2010.08.007_bb0070","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1136\/gut.2006.114363","article-title":"Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine","volume":"56","author":"Vernier-Massouille","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2010.08.007_bb0075","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1111\/j.1572-0241.2007.01187.x","article-title":"Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review","volume":"102","author":"Gisbert","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2010.08.007_bb0080","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug-induced liver disorders. Report of an international consensus meeting","volume":"11","author":"Benichou","year":"1990","journal-title":"J Hepatol"},{"key":"10.1016\/j.crohns.2010.08.007_bb0085","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/gut.50.4.485","article-title":"The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review","volume":"50","author":"Fraser","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2010.08.007_bb0090","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2036.2005.02636.x","article-title":"Incidence, risk factors and clinical course of thiopurine-induced liver injury in patients with inflammatory bowel disease","volume":"22","author":"Bastida","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2010.08.007_bb0095","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0016-5085(86)90947-9","article-title":"Azathioprine and hepatic venocclusive disease in renal transplant patients","volume":"90","author":"Katzka","year":"1986","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2010.08.007_bb0100","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/ard.48.4.342","article-title":"Azathioprine induced hepatic veno-occlusive disease in rheumatoid arthritis","volume":"48","author":"Lemley","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.crohns.2010.08.007_bb0105","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/gut.19.8.748","article-title":"Peliosis hepatis in recipients of renal transplants","volume":"19","author":"Degott","year":"1978","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2010.08.007_bb0110","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.29.9.1265","article-title":"Peliosis hepatis induced by 6-thioguanine administration","volume":"29","author":"Larrey","year":"1988","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2010.08.007_bb0115","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gut.20.6.531","article-title":"Idiopathic portal hypertension (perisinusoidal fibrosis) after renal transplantation","volume":"20","author":"Nataf","year":"1979","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2010.08.007_bb0120","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00042737-200012050-00016","article-title":"Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injury","volume":"12","author":"Arnott","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.crohns.2010.08.007_bb0125","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0399-8320(05)82136-0","article-title":"Azathioprine induced nodular regenerative hyperplasia in IBD patients","volume":"29","author":"Daniel","year":"2005","journal-title":"Gastroent\u00e9rol Clin Biol"},{"key":"10.1016\/j.crohns.2010.08.007_bb0130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/00042737-200103000-00013","article-title":"Veno-occlusive disease, nodular regenerative hyperplasia and hepatocellular carcinoma after azathioprine treatment in a patient with ulcerative colitis","volume":"13","author":"Russmann","year":"2001","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.crohns.2010.08.007_bb0135","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00042737-200605000-00018","article-title":"Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy","volume":"18","author":"Seiderer","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.crohns.2010.08.007_bb0140","first-page":"256","article-title":"Role of endothelial cell injury in the spectrum of azathioprine-induced liver disease after renal transplant: light microscopy and ultrastructural observations","volume":"83","author":"Haboubi","year":"1988","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2010.08.007_bb0145","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/hep.1840110512","article-title":"Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2, 500 autopsies and a new classification of benign hepatocellular nodules","volume":"11","author":"Wanless","year":"1990","journal-title":"Hepatology"},{"key":"10.1016\/j.crohns.2010.08.007_bb0150","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep.21258","article-title":"Nodular regenerative hyperplasia: not all nodules are created equal","volume":"44","author":"Reshamwala","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.crohns.2010.08.007_bb0155","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/01.pas.0000128665.12063.97","article-title":"Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel disease","volume":"28","author":"Geller","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.crohns.2010.08.007_bb0160","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0016-5085(03)00938-7","article-title":"6-thioguanine can cause serious liver injury in inflammatory bowel disease patients","volume":"125","author":"Dubinsky","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2010.08.007_bb0165","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jhep.2005.02.051","article-title":"A multicenter assessment of liver toxicity by MRI and biopsy in IBD patients on 6-thioguanine","volume":"43","author":"Seiderer","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.crohns.2010.08.007_bb0170","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/MEG.0b013e328334098f","article-title":"Usefulness of noninvasive tests in nodular regenerative hyperplasia of the liver","volume":"22","author":"Laharie","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.crohns.2010.08.007_bb0175","doi-asserted-by":"crossref","first-page":"S456","DOI":"10.1016\/S0016-5085(10)62112-9","article-title":"Low inter-observer agreement on nodular regenerative hyperplasia of the liver: an European inter-observer analysis","volume":"138","author":"Jharap","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2010.08.007_bb0180","first-page":"327","article-title":"Three cases of nodular regenerative hyperplasia of the liver following renal transplantation","volume":"3","author":"Buffet","year":"1988","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1016\/j.crohns.2010.08.007_bb0185","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/MEG.0b013e3283360021","article-title":"Nodular regenerative hyperplasia of the liver: survival and associated features in a UK case series","volume":"22","author":"Morris","year":"2010","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.crohns.2010.08.007_bb0190","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1080\/00365520701800266","article-title":"Histopathology of liver biopsies from a thiopurine-naive inflammatory bowel disease cohort: prevalence of nodular regenerative hyperplasia","volume":"43","author":"De Boer","year":"2008","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.crohns.2010.08.007_bb0195","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/gut.32.6.715","article-title":"Azathioprine induced liver disease: nodular regenerative hyperplasia of the liver and perivenous fibrosis in a patient treated for multiple sclerosis","volume":"32","author":"Mion","year":"1991","journal-title":"Gut"},{"issue":"14","key":"10.1016\/j.crohns.2010.08.007_bb0200","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1182\/blood-2009-07-230656","article-title":"Oral 6-mercaptopurine vs. Oral 6-thioguanine and veno-occlusive disease in children with standard risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial","volume":"115","author":"Stork","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.crohns.2010.08.007_bb0205","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.dld.2006.10.007","article-title":"Toxicity of 6-thioguanine: no hepatotoxicity in a series of IBD patients treated with long-term, low dose 6-thioguanine. Some evidence for dose or metabolite level dependent effects?","volume":"39","author":"Gilissen","year":"2007","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.crohns.2010.08.007_bb0210","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.dld.2007.10.013","article-title":"Absence of nodular regenerative hyperplasia after low-dose 6-thioguanine maintenance therapy in inflammatory bowel disease patients","volume":"40","author":"de Boer","year":"2008","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.crohns.2010.08.007_bb0215","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.dld.2004.09.029","article-title":"Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations","volume":"37","author":"Al Hadithy","year":"2005","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.crohns.2010.08.007_bb0220","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/S0016-5085(10)60283-1","article-title":"Liver histology of IBD patients who are treated with 6-Thioguanine due to failure of conventional thiopurines reveals very few cases of nodular regenerative hyperplasia","volume":"138","author":"van Asseldonk","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2010.08.007_bb0225","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/hep.510230326","article-title":"Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease","volume":"23","author":"DeLeve","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.crohns.2010.08.007_bb0230","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/ncpgasthep1000","article-title":"Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD","volume":"4","author":"de Boer","year":"2007","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.crohns.2010.08.007_bb0235","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1111\/j.1572-0241.2007.01530.x","article-title":"6-thioguanine associated nodular regenerative hyperplasia in patients with inflammatory bowel disease may induce portal hypertension","volume":"102","author":"Ferlitsch","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.crohns.2010.08.007_bb0240","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/gut.51.2.275","article-title":"Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients","volume":"51","author":"Hillaire","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.crohns.2010.08.007_bb0245","first-page":"721","article-title":"Nodular regenerative hyperplasia of the liver associated with a Factor V Leiden mutation","volume":"10","author":"Levy","year":"1998","journal-title":"Eur J Gastroenterol Hepatol"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994610001352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994610001352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/5\/1\/48\/7799780\/5-1-48.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T15:05:35Z","timestamp":1503414335000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2010.08.007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S1873994610001352"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2010.08.007","relation":{},"ISSN":["1873-9946"],"issn-type":[{"value":"1873-9946","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}